Dozens of Zantac lawsuits filed in New York state courts have been consolidated for pretrial proceedings over claims the recalled heartburn drug may cause cancer.
Merck indicates it will remove nitrosamine contaminants from Januvia and Janumet by the end of 2023.
Despite dismissal of federal Zantac lawsuits, plaintiffs continue to file claims in state courts.
A federal judge has cleared Valsartan NDMA lawsuits to proceed after rejecting a call by defendants to reconsider the admissibility of plaintiffs' expert witnesses following the recent dismissal of Zantac…
Parties have reportedly reached a settlement agreement to resolve the first Zantac lawsuit scheduled to go to trial in California state court.
An FDA inspection of the independent testing lab Valisure's former pharmacy division found it failed to identify illegitimate drug products and raised questions about the company's knowledge of the Food,…
A judge has ordered all federal Zantac lawsuits dismissed after questioning the science behind claims that the recalled heartburn drug is linked to an increased risk of cancer.
A Bloomberg report highlights how the independent laboratory, Valisure, has consistently discovered dangerous, potentially cancer-causing chemicals in products like Zantac and sunscreen before the FDA.
The FDA has been caught off-guard by the number of drugs being recalled for nitrosamine contamination and is likely to update a 2020 guidance to better address the problem according…
Plaintiffs involved in Zantac litigation have submitted new evidence from a recently published study which links Zantac use to four different types of cancer.
